A consecutive centrifugal method for concentration of human enteric viruses in water samples.

A consecutive centrifugal method was developed to concentrate enteric viruses from water. Using five selected human enteric viruses, the recovery rates were evaluated and compared with results from NanoCeram filtration methods. The highest recovery rate was achieved for coxsackievirus (78.11 %, 42.97-101.39), and the lowest rate was for adenovirus (32.84 %, 19.68-66.20). In comparison with NanoCeram disc filtration with beef-extract flocculation (BE), the recovery rate was increased for all viruses. The rate of increase varied from a low of 8.24 % (astroviruses) to a high of 24.22 % (noroviruses). The NanoCeram filtration with BE was further modified by NaPP buffer plus one-step centrifugation using a Centricon plus-70 device. The modified method further increased the concentrations of viruses in the sample. Virus concentration was increased to 19.45 ± 7.19-fold for rotavirus, 19.40 ± 6.54-fold for norovirus, 16.10 ± 7.61-fold for coxsackievirus, 12.80 ± 3.00-fold for astrovirus and 11.97 ± 6.94-fold for adenovirus compared to the NanoCeram filtration with BE. Subsequent cell culture showed that the infectivity of the viruses was not altered by any of the three methods. Three methods will provide testing labs with choices for cost-effective approaches to concentrate viruses from water.

Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease.

Non-alcoholic fatty acid liver disease (NAFLD) is a reputed global health concern, affecting children and young adults. Accumulating evidence suggests that edible fungi polysaccharides have the potential to relieve NAFLD. Our previous study found that Auricularia cornea var. Li. polysaccharides (ACP) could improve immune by regulating gut microbiota. However, its NAFLD-alleviating potentials have been scarcely reported. This study analyzed the protective effects of Auricularia cornea var. Li. polysaccharides on high-fat diet (HFD)-induced NAFLD and mechanistic actions. We first analyzed the histology and hepatic lipid profile of animals to evaluate this variant's ameliorating effects on NAFLD. Then, antioxidant and anti-inflammatory potentials of ACP were studied. Finally, we explored changes in the gut microbiome diversity for mechanistic insights from the gut-liver region. Results showed that supplementation with ACP substantially reduced homeostasis model assessment-insulin resistance (HOMA-IR), body fat, liver index rates and weight gain (p < 0.05). This variant also improved HDL-C levels while decreasing triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels which were initially triggered by HFD. ACP mediation also decreased the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels considerably with H&E technique indicating that it can reduce liver lipid accumulation, thus lowering liver damages risks (p < 0.05). The antioxidant potentials of ACP were also demonstrated as it decreased the hepatic levels of malondialdehyde (MDA) and increased the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX). Proinflammatory markers like IL-6, IL-1ß and TNF-α concentrations were decreased by ACP supplementation, accompanied with increased IL-4 levels. Finally, ACP supplementation regulated the intestinal microbiota to near normal patterns. In all, ACP protects HFD-induced NAFLD by improving liver characteristics and regulating colonic flora composition, our findings assert that ACP can be a promising strategy in NAFLD therapy.